The Korea Drug
Development Fund to host the 2025 KDDF Science Conference
- Discussions on
novel mechanisms centered on TPD and CGT, alongside AI-driven drug development
strategies and beyond
The Korea Drug Development Fund (KDDF) announced that it will host the ‘2025 KDDF Science Conference’ from August 28 to 30 at Alpensia in Pyeongchang, Gangwon Province.
Now in its fifth year, the conference is expected to convene approximately 130 experts representing industry, academia, research institutes, and the medical community. The program will center on advancing research into novel mechanisms and exploring next-generation drug development strategies, with particular emphasis on artificial intelligence (AI)-driven technologies, including targeted protein degradation (TPD) and cellular and gene therapy (CGT).
The special lecture was delivered by Cha Kwang-ryeol, Director of the Global Research Institute at Cha Hospital and Cha Bio Group, a globally recognized scholar renowned for pioneering innovations in reproductive medicine. His achievements include the world's first successful pregnancy and live birth using immature oocytes in 1989, the development of vitrification-based oocyte cryopreservation in 1998, and the establishment of the world's first egg bank in 1999. At present, Cha Bio Group continues to lead advancements in cutting-edge regenerative medicine, including stem cell-based cell therapy, immune cell therapy, tissue regeneration, and research on delaying aging.
